Stockscreener 앱 받기
227.41
0.21%
-0.47
시간 외 거래:
225.00
-2.41
-1.06%
전일 마감가:
$227.88
열려 있는:
$228.1
하루 거래량:
786.45K
Relative Volume:
0.74
시가총액:
$33.13B
수익:
$5.40B
순이익/손실:
$1.49B
주가수익비율:
22.48
EPS:
10.1168
순현금흐름:
$1.78B
1주 성능:
-2.15%
1개월 성능:
-11.27%
6개월 성능:
-16.76%
1년 성능:
+2.41%
1일 변동 폭
$226.43
$230.15
1주일 범위
$226.43
$235.80
52주 변동 폭
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD vs ISRG, BDX, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 개시 | Citigroup | Buy |
| 2025-09-02 | 업그레이드 | CLSA | Hold → Outperform |
| 2025-07-15 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 개시 | Morgan Stanley | Overweight |
| 2025-01-16 | 개시 | Goldman | Buy |
| 2025-01-10 | 개시 | Piper Sandler | Neutral |
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) - Yahoo Finance Australia
ResMed Inc (NYSE:RMD): A Quality Dividend Stock Built on Strong Fundamentals - ChartMill
ResMed Inc. $RMD Shares Acquired by Mirabella Financial Services LLP - MarketBeat
ResMed Inc Stock (ISIN: AU000000RMD6) Faces Pressure Amid Recent Declines: What European Investors N - AD HOC NEWS
Danske Bank A S Buys New Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
Captrust Financial Advisors Increases Stake in ResMed Inc. - National Today
Captrust Financial Advisors Buys 27,565 Shares of ResMed Inc. $RMD - MarketBeat
Achmea Investment Management B.V. Decreases Stake in ResMed Inc. $RMD - MarketBeat
With global populations ageing, are ResMed shares a good buy today? - The Motley Fool Australia
Why Cochlear and ResMed shares could be strong buys - The Motley Fool Australia
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
ResMed Stock In Shambles: Down 6.7% With 5-Day Losing Streak - Trefis
Is Resmed Shares a Smart Addition to Your Investment Portfolio at This Time? - Bitget
ResMed (RMD) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Resmed Stock the Right Pick for Your Portfolio Now? - Yahoo Finance
Mirabella Financial Services LLP Purchases 5,562 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Stock Plummets 8.8% With 5-Day Losing Streak - Trefis
Short Interest in ResMed Rises 17.2% - National Today
ResMed Stock Slides -8.8% With A 5-Day Losing Spree - Trefis
Short Interest in ResMed Inc. (NYSE:RMD) Grows By 17.2% - MarketBeat
California Public Employees Retirement System Has $78.58 Million Position in ResMed Inc. $RMD - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating (NYSE:RMD) - Seeking Alpha
ResMed, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Stifel reiterates Hold on ResMed stock, keeps $265 price target By Investing.com - Investing.com India
Aquatic Capital Management Boosts ResMed Stake by 106% - National Today
Aquatic Capital Management LLC Buys 12,642 Shares of ResMed Inc. $RMD - MarketBeat
What are analysts saying about ResMed, Downer, and Nuix shares? - The Motley Fool Australia
RMD SEC FilingsResmed 10-K, 10-Q, 8-K Forms - Stock Titan
ResMed CEO Farrell Exercises Options and Sells Shares Under 10b5-1 Plan - TipRanks
ResMed Inc Stock (ISIN: AU000000RMD6) Faces Pressure Amid Share Price Pullback and Valuation Debate - AD HOC NEWS
Capital Impact Advisors LLC Boosts Holdings in ResMed Inc. $RMD - MarketBeat
Is It Time To Reconsider ResMed (RMD) After The Recent Share Price Pullback - Yahoo Finance
3 Reasons Not to Sleep on ResMed Stock - AOL.com
2Xideas AG Acquires 8,397 Shares of ResMed Inc. $RMD - MarketBeat
ResMed (NYSE:RMD) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Landscape Capital Management L.L.C. Boosts Stake in ResMed Inc. $RMD - MarketBeat
Russell Investments Group Boosts Stake in ResMed - National Today
Mackenzie Financial Corp Trims Stock Position in ResMed Inc. $RMD - MarketBeat
Russell Investments Group Ltd. Has $30.85 Million Position in ResMed Inc. $RMD - MarketBeat
Bank of Montreal Can Sells 128,166 Shares of ResMed Inc. - National Today
Bank of Montreal Can Sells 128,166 Shares of ResMed Inc. $RMD - MarketBeat
ChartWatch ASX Scans: Whitehaven Coal, New Hope Corp, Yancoal, CSL, Charter Hall, Resmed, Seek, Zip Co. - Market Index
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Legal & General Group Plc Reduces ResMed Inc. Stake - National Today
Legal & General Group Plc Reduces Stake in ResMed Inc. - National Today
Schroder Investment Management Group Boosts Stake in ResMed Inc. - National Today
Is ResMed Stock Underperforming the Nasdaq? - Yahoo Finance
Schroder Investment Management Group Boosts Stock Holdings in ResMed Inc. $RMD - MarketBeat
Legal & General Group Plc Has $262.29 Million Position in ResMed Inc. $RMD - MarketBeat
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.15%
0.96%
자본화:
|
볼륨(24시간):